These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22455165)

  • 1. Fecal immunochemical testing (FIT) demonstrates success in colorectal cancer prevention.
    S D Med; 2012 Mar; 65(3):115. PubMed ID: 22455165
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers.
    Terhaar sive Droste JS; Oort FA; van der Hulst RW; van Heukelem HA; Loffeld RJ; van Turenhout ST; Ben Larbi I; Kanis SL; Neerincx M; Räkers M; Coupé VM; Bouman AA; Meijer GA; Mulder CJ
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):272-80. PubMed ID: 21135261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.
    van Roon AH; Hol L; van Vuuren AJ; Francke J; Ouwendijk M; Heijens A; Nagtzaam N; Reijerink JC; van der Togt AC; van Ballegooijen M; Kuipers EJ; van Leerdam ME
    Am J Gastroenterol; 2012 Jan; 107(1):99-107. PubMed ID: 22108450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.
    Hoffman RM; Steel S; Yee EF; Massie L; Schrader RM; Murata GH
    Prev Med; 2010; 50(5-6):297-9. PubMed ID: 20307568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. South Dakota council on colorectal cancer releases the 2013 colorectal cancer monograph.
    Schroeder SD
    S D Med; 2013 Mar; 66(3):113. PubMed ID: 23544301
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia.
    Lane JM; Chow E; Young GP; Good N; Smith A; Bull J; Sandford J; Morcom J; Bampton PA; Cole SR
    Gastroenterology; 2010 Dec; 139(6):1918-26. PubMed ID: 20723544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of the four major cancers in South Dakota.
    Clarke J
    S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. March is Colorectal Cancer Awareness Month.
    Bachwich D
    S D Med; 2008 Mar; 61(3):109. PubMed ID: 18491466
    [No Abstract]   [Full Text] [Related]  

  • 13. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer--now and the near future.
    Bromer MQ; Weinberg DS
    Semin Oncol; 2005 Feb; 32(1):3-10. PubMed ID: 15726501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing colorectal cancer screening in South Dakota.
    Seeff L; Schmidt N
    S D Med; 2010; Spec No():49-51. PubMed ID: 20397491
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality focus: Current guidelines for colorectal cancer prevention and detection.
    Herrick LM
    S D Med; 2014 Mar; 67(3):112. PubMed ID: 24669590
    [No Abstract]   [Full Text] [Related]  

  • 17. Which colorectal cancer screening test is best?
    Mandel JS
    J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening, surveillance, and prevention of colorectal cancer.
    Lieberman D
    Gastrointest Endosc Clin N Am; 2008 Jul; 18(3):595-605, xi. PubMed ID: 18674706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colorectal cancer: Japanese screening program today].
    Saito H
    Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):357-60. PubMed ID: 9101541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New stool screening tests for colorectal cancer.
    Young GP; Cole S
    Digestion; 2007; 76(1):26-33. PubMed ID: 17947816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.